Direct Evidence for the Involvement of the Mesolimbic κ-Opioid System in the Morphine-Induced Rewarding Effect Under an Inflammatory Pain-Like State
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Recent clinical studies have demonstrated that when morphine is used to control pain in cancer patients, psychological dependence is not a major concern. The present study was undertaken to ascertain the modulation of psychological dependence on morphine under a chronic pain-like state in rats. The prototypical mu-opioid receptor agonist morphine (8 mg/kg, i.p.) induced a dose-dependent place preference. In the present study, we found that an inflammatory pain-like state following formalin injection significantly suppressed the morphine-induced rewarding effect. This effect was almost reversed by s.c. pretreatment with the kappa-opioid receptor antagonist nor-binaltorphimine (nor-BNI, 5 mg/kg). Furthermore, the morphine-induced increase in dopamine (DA) turnover in the limbic forebrain was significantly inhibited by treatment with formalin. This inhibition was also suppressed by pretreatment with nor-BNI. In addition, in vivo microdialysis studies clearly showed that the morphine-induced increase in the extracellular levels of DA and its metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, in the nucleus accumbens (N.Acc.) was significantly decreased in rats that had been pretreated with formalin. This effect was in turn reversed by the microinjection of a specific dynorphin A antibody into the N.Acc. These findings suggest that the inflammatory pain-like state induced by formalin injection may have caused a sustained activation of the kappa-opioidergic system w…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, although a few mouse studies have shown some increase in drinking with chronic pain in a neuropathic model of pain (González-Sepúlveda et al., 2016) and osteoarthritis model of pain (Butler et al., 2017), the data to date that show increases in the rewarding effects of opioids or increases in opioid self-administration after chronic pain have been limited (Ozaki et al., 2002;Narita et al.”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Narita et al., 2005
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,014
Activity-dependent neuronal plasticity following tissue injury and inflammation
Dubner, R., & Ruda, M. A. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90019-5 · Cited by 926 · cited 2×
“Previous studies have demonstrated that the levels of dynorphin and pre-prodynorphin mRNA in some brain regions are increased under inflammatory pain-like states induced by the injection of carrageenan and complete Freund’s adjuvant (Millan et al, 1987; Dubner and Ruda, 1992).”
BackgroundResultIncreased probability of GABA release during withdrawal from morphine
Bonci, A., & Williams, J. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00796.1997 · Cited by 286 · cited 7×
“Furthermore, this pain-like state leads to a reduction in m-receptor function in the ventral tegmental area (VTA; Ozaki et al, 2002, 2003), which is the origin of the mesolimbic dopaminergic system and the major neural substrate of the rewarding effect produced by opioids (Koob, 1992; Nestler, 1996; Narita et al, 2001…”
BackgroundInfluentialUnder Siege: The Brain on Opiates
Nestler, E. J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80110-5 · Cited by 260
Regulations of opioid dependence by opioid receptor types
Narita, M., Funada, M., & Suzuki, T. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00099-1 · Cited by 190
Self-citationBlockade of morphine reward through the activation of κ-opioid receptors in mice
Funada, M., Suzuki, T., Narita, M., Misawa, M., & Nagase, H. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90026-y · Cited by 166
Self-citation
Cited by
Items 101–131 of 131
Interactions of pain and opioids on conditioned place preference in rodents
Barattini, A. E., & Pahng, A. R. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06719-1 · Cited by 5
“…Fenu et al. 2006; Rutten et al. 2010; van der Kam et al. 2008; You et al. 2019; Zhang et al. 2012), or did not (Harton et al. 2017; Lim et al. 2014; Narita et al. 2005; Rutten et al. 2010; Rutten, van der Kam, et al., 2011; Suzuki et al. 1996; Taylor et al. 2015; Woller et al. 2012) produce CPP…”
InfluentialRosa, H. Z., Segat, H. J., Barcelos, R. C. S., Roversi, K., Rossato, D. R., de Brum, G. F., & Bürger, M. E. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173000 · Cited by 5
The Self-administration of Analgesic Drugs in Experimentally Induced Chronic Pain
Wade, C. L., & Fairbanks, C. A. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_344 · Cited by 5
Liu, Z., Liu, A., Chen, J., Chai, J., Liu, P., Ye, R.-F., Liu, J., & Wang, Y.-J. (2025) · Pain Research and Management · doi:10.1155/prm/5656675 · Cited by 4
“Subsequently, we assessed the efect of KOR antagonist nor-BNI on dezocine-induced action. nor-BNI was administered subcutaneously at 5mg/kg [32], and its efects were assessed 24h later.”
Involvement of μ ‐ and δ ‐opioid receptor function in the rewarding effect of (±)‐pentazocine
Mori, T., Itoh, T., Yoshizawa, K., Ise, Y., Mizuo, K., Saeki, T., Komiya, S., Masukawa, D., Shibasaki, M., & Suzuki, T. (2014) · Addiction Biology · doi:10.1111/adb.12169 · Cited by 5
“We previously showed that inflammatory pain reduced morphine-induced rewarding effects through overactivation of the κ-opioid receptor system (Suzuki et al. 1999; Narita et al. 2005).”
BackgroundMethodResultSelf-citationZubieta, J.-K. (2008) · Elsevier eBooks · doi:10.1016/b978-012370880-9.00199-7 · Cited by 4
Black, J. W., & Meyer, L. H. (1992) · PubMed · Cited by 11
Brewer, R., Blum, K., Bowirrat, A., Modestino, E. J., Baron, D. A., Badgaiyan, R. D., Moran, M., Boyett, B., & Gold, M. S. (2020) · Current Psychopharmacologye · doi:10.2174/2211556009999200628093231 · Cited by 3
Fentanyl Analogs Exert Antinociceptive Effects via Sodium Channel Blockade in Mice
Kasai, S., Ogawa, N., Takagi, M., Takahashi, Y., Makino, K., Arita, H., Takahashi, H., & Yoshizawa, K. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b24-00048 · Cited by 3
Schneider, R., & Ardenghi, P. (2010) · Revista Brasileira de Plantas Medicinais · doi:10.1590/s1516-05722010000300014 · Cited by 3
Chen, X., Wang, T., Lin, C., & Chen, B. (2014) · PubMed · Cited by 4
Working memory-based and -free reward prediction in a dual dopamine system in the basal gangliaPreprint
Yoshizawa, T., Miyamura, Y., Ochi, Y., Hira, R., Funahashi, M., Sakai, Y., Cui, Y., & Isomura, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.06.531239 · Cited by 2
“For example, dynorphin, an endogenous opioid, inhibits striatal DA release by activating kappa-opioid receptors at the axon terminals of midbrain DA neurons (Narita et al., 2005).”
BackgroundPan, Y., Liu, S., Malik, A., Chien, R., Liu, J. F., Nicholson, L. V. B., Xu, J., Didehvar, K., Rai, V., Rouzic, V. L., et al. (2026) · Research Square · doi:10.64898/2026.08.06.743062 · Cited by 2
Treatment of Cancer Pain and Medical Narcotics
Suzuki, T. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.15-00216 · Cited by 1
Self-citationNarita, M., Niikura, K., Yamashita, A., Ikegami, D., Kuzumaki, N., Narita, M., & Suzuki, T. (2014) · Contemporary clinical neuroscience · doi:10.1007/978-1-4939-1856-0_4 · Cited by 1
Self-citationInvestigative Analysis of Inappropriate Opioid Use for Cancer Outpatient
Shimizu, K., Ikenaga, M., Sugita, T., Takeohara, M., Kazuno, C., Kubota, T., Okoshi, T., Aoki, S., Kamura, R., & Imamura, T. (2016) · Palliative Care Research · doi:10.2512/jspm.11.174 · Cited by 1
Sotomayor-Sobrino, M. A., Ochoa-Aguilar, A., Tenorio, E. P., León‐Olea, M., Velasco‐González, R., Luna-Mendoza, I., & Acevedo, C. G. (2018) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2018.82004 · Cited by 1
Inflammatory and neuropathic pain impact on the opioid function in the mesocorticolimbic system
Campos‐Jurado, Y., Cuitavi, J., Landsberg, N., Lorente, J. D., & Hipólito, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820589-1.00045-2 · Cited by 1
川村, 郁., 川合, 甲., 佐野, 吉., 直美, 久., 寺町, 真., 貴詞, 水., 幸男, 遠., 寛子, 斎., & Hasegawa, T. (2009) · Palliative Care Research · doi:10.2512/jspm.4.214 · Cited by 1
Fairbanks, C. A., & Peterson, C. D. (2014) · Contemporary clinical neuroscience · doi:10.1007/978-1-4939-1856-0_6
Grinde, B. (2012) · SpringerBriefs in well-being and quality of life research · doi:10.1007/978-94-007-4393-9_3
Psychological dependence on opioid analgesics
Yoshizawa, K., Narita, M., & Suzuki, T. (2013) · Folia Pharmacologica Japonica · doi:10.1254/fpj.142.22
Self-citation薬物依存の評価法と戦略 7 薬物依存時におけるシナプス可塑性とグリア細胞:グリアから依存を考える
Narita, M., Miyatake, M., Suzuki, M., & Suzuki, T. (2005) · Folia Pharmacologica Japonica · doi:10.1254/fpj.126.43
Self-citationPain clinic and drugs of abuse
Suzuki, T., Yajima, Y., & Narita, M. (2005) · Journal of Japan Society of Pain Clinicians · doi:10.11321/jjspc1994.12.365
Self-citationNarita, M., Suzuki, M., Narita, M., Niikura, K., Shimamura, M., Kuzumaki, N., Yajima, Y., & Suzuki, T. (2004) · doi:10.11321/jjspc1994.11.397
Self-citationPalmisano, M. (2017) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/7974
Yu, W. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/mwh5-cq56
Zubieta, J.-K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-805408-6.00199-8
Peterson, C. D., & Fairbanks, C. A. (2025) · Pain · doi:10.1097/j.pain.0000000000003607
Derrien, P.-A. (2023) · theses.fr (ABES) · doi:10.70675/62e3aab4z35bez495eza377z57ad093cebf6
Wade, C. L., & Fairbanks, C. A. (2014) · Contemporary clinical neuroscience · doi:10.1007/978-1-4939-1856-0_1
Metadata
- Authors
- Narita, M., Kishimoto, Y., Ise, Y., Yajima, Y., Misawa, K., & Suzuki, T.
- Affiliations
- Hoshi University (JP)
- Corresponding author
- Narita, Minoru
- Suzuki, Tsutomu
- Venue
- Neuropsychopharmacology
- Published
- 2004-07-14
- Volume
- 30
- Issue
- 1
- Pages
- 111-118
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1989362268
- Cited by
- 128
- References
- 21
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 1 · 2021: 7 · 2020: 10 · 2019: 9 · 2018: 7 · 2017: 4 · 2016: 6 · 2015: 7 · 2014: 11 · 2013: 7 · 2012: 7
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- morphine, kappa opioid receptor, mesolimbic dopamine system, inflammatory pain, formalin-induced pain, nor-binaltorphimine, nucleus accumbens, dopamine turnover, dynorphin A, place preference, morphine reward, psychological dependence, cancer pain
- MeSH terms
- Animals, Brain Chemistry, Conditioning, Operant, Dopamine, Dynorphins, Edema, Foot, Formaldehyde, Inflammation, Limbic System, Male, Microinjections, Morphine, Naltrexone, Narcotic Antagonists, Narcotics, Pain, Pain Measurement, Reward, Rats, Sprague-Dawley, Receptors, Opioid, kappa, Microdialysis, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.